Akero Therapeutics has hit a home run, reporting statistically significant results in two key 96-week metabolic dysfunction-associated steatohepatitis (MASH) analyses to send its stock up about 100%.

After 96 weeks, 39% of patients offered a 50-mg dose of efruxifermin showed a clinically meaningful reduction in liver fibrosis, or scarring, without other symptoms of MASH getting worse ...

Fortnite's February 2025 Crew Pack features Haruka of the Masks outfit,new back bling, and pickaxe. Fans excited for Japanese-themed skin. January's Crew Pack had mixed reviews, but February's ...

Shares of Akero ascended by 115% in early Monday trading upon the news. MASH-associated cirrhosis patients “face a poor prognosis,” Catriona Yale, chief development officer at Akero, said on an ...

Pokemon TCG Pocket has announced its latest expansion called the Space-Time Smackdown pack. This set features two booster packs that highlight Generation IV pocket monsters, Dialga and Palkia, in ...